· The best-selling real-time CGM in the world¹ is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app
· New system has the fastest sensor warmup on the market,* with no fingersticks† or scanning required
· Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range²,³
EDINBURGH, Scotland & SAN DIEGO, March 15 (Bernama-BUSINESS WIRE) — DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with diabetes in Europe age two years and older, including pregnant women.
- Syrian Heritage At Risk As U.S. Blockade Threatens Antiquities: Official
- Iraqi Parliament Fails To Elect New Speaker
- Israeli Occupation Army Continues ‘Barbaric’ Attacks On Gaza’s Jabalia Camp, Urges Civilian Evacuation
- Palestinian Death Toll In Gaza Rises To 35,386: Health Authorities
- 21 Years After U.S.-Led Invasion, Iraq Strives To Retrieve Looted Antiquities
- DPRK Test-Fires Tactical Ballistic Missile Using New Navigation System
- Gaza Tops Agenda As Arab League Summit Kicked Off In Bahrain
- Iran Dismisses U.S. Accusations Of Arms Transfer To Houthis
- Two Suspected Rebels Killed In Philippine Clash
- Lawrence Wong Sworn In As Singapore Prime Minister
